Source: Annual Congress 2001 - Etiology of LRTI
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
E. B. Koroleva, A. M. Borodin, A. M. Katsuba (Nizniy Novgorod, Russia). Monitoring of Mycoplasma pneumoniae and Chlamydia pneumoniae in young patients with community-acquired pneumonia (CAP). Eur Respir J 2001; 16: Suppl. 31, 938

Member's Comments

No comment yet.

Related content which might interest you: Mycoplasma pneumoniae and Chlamydia pneumoniae infections in children with pneumonia Source: Eur Respir J 2001; 17: 241-245 Year: 2001 Severe Chlamydia pneumoniae community-acquired pneumonia Source: Eur Respir J 2003; 22: Suppl. 45, 545s Year: 2003 Macrolide-resistant Mycoplasma pneumoniae in paediatric pneumonia Source: Eur Respir J 2011; 37: 1522-1524 Year: 2011 Is Chlamydia pneumoniae an important pathogen in patients with community-acquired pneumonia? Source: Eur Respir J 2003; 21: 741-742 Year: 2003 Chlamydia species as a cause of community-acquired pneumonia in Canada Source: Eur Respir J 2003; 21: 779-784 Year: 2003 Chlamydia pneumoniae and Mycoplasma pneumonia infection in children respiratory diseases Source: Virtual Congress 2021 – Acute paediatric respiratory infections Year: 2021 Azithromycin treatment failure in macrolide-resistant Mycoplasma pneumoniae pneumonia Source: Eur Respir J 2010; 36: 969-971 Year: 2010 Chlamydia pneumoniae pneumonia and Mycoplasma pneumoniae pneumonia: comparison of clinical findings and CT findings Source: Eur Respir J 2004; 24: Suppl. 48, 488s Year: 2004 Fast replicating strains of streptococcus pneumoniae are associated with severe community-acquired pneumonia Source: Annual Congress 2009 - Aetiology and treatment of community-acquired pneumonia Year: 2009 Streptococcus pneumoniae is the main causative agent of community-acquired pneumonia Source: Eur Respir J 2002; 20: Suppl. 38, 608s Year: 2002 Community-acquired pneumonia (CAP) caused by mycoplasma pneumoniae or chlamydophila pneumoniae in children: Are there reliable signs/symptoms for clinical diagnostics? Source: Annual Congress 2013 –The burden of respiratory infections in children Year: 2013 Chlamydia pneumoniae infection in asthmatic patients Source: Annual Congress 2009 - Asthma assessment and original therapeutic approaches Year: 2009 Chlamidia pneumoniae and Mycoplasma pneumoniae infection of airways in patients with broncho-obstructive diseases Source: Eur Respir J 2005; 26: Suppl. 49, 409s Year: 2005 Chlamydophila pneumoniae and mycoplasma pneumoniae infection of airways in patients with bronchoobstructive diseases Source: Annual Congress 2008 - Lower respiratory tract infection: from outbreak to prognostic tests Year: 2008 Chlamydia pneumoniae and mycoplasma pneumoniae seropositivities in children with bronchial asthma Source: Eur Respir J 2006; 28: Suppl. 50, 849s Year: 2006 Pneumonia caused by Mycoplasma pneumoniae Source: Eur Respir J 2005; 26: Suppl. 49, 409s Year: 2005 Peculiarities of community-acquired pneumonia course, caused by multiresistant strains of S. pneumoniae Source: Eur Respir J 2006; 28: Suppl. 50, 165s Year: 2006 A study of the prevalence of streptococcus pneumoniae serotypes in patients hospitalised for community-acquired pneumonia Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues Year: 2016 Community-acquired pneumonia in Europe: causative pathogens and resistance patterns Source: Eur Respir J 2002; 20: 20S-27S Year: 2002 Clinical features of Mycoplasma pneumoniae infections in Bulgarian children Source: Virtual Congress 2020 – Epidemiology of paediatric respiratory diseases Year: 2020